Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection (Q34291666)

1 August 2017

title

Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection (English)

1 reference

eradication of infectious diseases

1 August 2017

0 references

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

A Nagahara

1 reference

1 August 2017

H Miwa

1 reference

1 August 2017

R Ohkura

1 reference

1 August 2017

T Yamada

1 reference

1 August 2017

K Sato

1 reference

1 August 2017

M Hojo

1 reference

1 August 2017

N Sato

1 reference

1 August 2017

publication date

1 June 2001

1 reference

Journal of Gastroenterology and Hepatology

1 August 2017

published in

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

page(s)

613-618

1 reference

Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02491.X

Treatment after failure: the problem of "non-responders".

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02491.X

A survey of gastroenterologists' perceptions and practices related to Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02491.X

Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02491.X

Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02491.X

Antibiotic resistance problems with Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02491.X

A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02491.X

Clinical relevance of resistant strains of Helicobacter pylori: a review of current data

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02491.X

Usefulness of the [13C]-urea breath test for detection of Helicobacter pylori infection in fasting patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02491.X

Effect of Fasting Subjects’ Posture on 13C‐Urea Breath Test for Detection of Helicobacter pylori Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02491.X

Intrahepatic modulation of portal pressure and its role in portal hypertension. Role of endothelins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02491.X

Efficacy of a multistep strategy for Helicobacter pylori eradication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02491.X

Assessment of a new triple agent regimen for the eradication of Helicobacter pylori and the nature of H. pylori resistance to this therapy in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02491.X

10.1046/J.1440-1746.2001.02491.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference